GlaxoSmithKline Forms US$650 M Epigenetics Alliance with Epizyme
By Heather Cartwright
Pharma Deals Review: Vol 2011 Issue 1 (Table of Contents)
Published: 24 Jan-2011
DOI: 10.3833/pdr.v2011.i1.1423 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Cambridge, Massachusetts-based Epizyme, which was formed in 2007, has signed its first major deal, a global epigenetics alliance with GlaxoSmithKline (GSK)...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS